NK will never discuss 'sovereignty' with US, says Kim Yo-jong
Adults arrested for proxy purchasing of cigarettes, receiving $3 from teens
Yoon accepts broadcasting watchdog chief's resignation ahead of impeachment motion
Yoon revives policy chief of staff position, reshuffles all senior secretaries
[Exclusive] PUBG developer wins lawsuit against Chinese copycat in US
Drug Ministry cancels approval of 6 botulinum productsBy Kan Hyeong-woo
Published : Dec. 2, 2021 - 18:32
The Drug Ministry said the drugs were being sold in the country without obtaining the state approval to sell them in the domestic market.
The drugs are four of Hugel’s Botulax units and two of Pharma Research Bio’s ReNTox units.
The Drug Ministry will also shut down Pharma Research Bio’s production for six months, citing that the biopharmaceutical firm’s ReNTox units were exclusively approved for exports but they were sold in the country.
The ministry ordered both companies to recall and discard the cancelled drugs and asked medical institutions to cooperate in the recall process.
“We will do our best to crack down on and punish acts that threaten public health. We will guide and inspect the industry and provide safe medicines,” the ministry said in a press release.
Yoon accepts broadcasting watchdog chief's resignation
S. Korea, US, Japan, Australia jointly announce sanctions on NK
S. Korea to expand telemedicine services in remote areas